Werewolf Therapeutics Inc...
(HOWL)
undefined
undefined%
At close: undefined
1.70
2.72%
After-hours Dec 13, 2024, 07:23 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | 19.94M | 16.40M | - | - | - |
Cost of Revenue | 38.91M | 2.51M | 735.00K | 777.00K | 463.00K |
Gross Profit | -18.96M | 13.89M | -735.00K | -777.00K | -463.00K |
Operating Income | -40.50M | -56.06M | -50.09M | -22.40M | -9.94M |
Interest Income | 7.42M | 1.91M | 104.00K | 101.00K | 372.00K |
Pretax Income | -37.37M | -53.81M | -49.98M | -15.04M | -10.25M |
Net Income | -37.37M | -51.56M | -49.77M | -14.94M | -10.99M |
Selling & General & Admin | 18.67M | 18.70M | 14.82M | 5.76M | 3.60M |
Research & Development | 41.78M | 53.76M | 35.27M | 16.64M | 6.34M |
Other Expenses | - | 2.25M | 104.00K | 7.26M | 430.00K |
Operating Expenses | 60.45M | 72.46M | 50.09M | 22.40M | 9.94M |
Interest Expense | 3.14M | - | - | - | 372.00K |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 60.45M | 72.46M | 50.09M | 22.40M | 9.94M |
Income Tax | - | -2.25M | -216.00K | -101.00K | 742.00K |
Shares Outstanding (Basic) | 35.65M | 28.86M | 27.31M | 28.66M | 28.66M |
Shares Outstanding (Diluted) | 35.65M | 28.86M | 27.31M | 28.66M | 28.66M |
EPS (Basic) | -1.05 | -1.79 | -1.82 | -0.52 | -0.38 |
EPS (Diluted) | -1.05 | -1.79 | -1.82 | -0.52 | -0.38 |
EBITDA | -32.47M | -51.30M | -49.25M | -14.26M | -9.41M |
Depreciation & Amortization | 1.76M | 2.51M | 735.00K | 777.00K | 463.00K |